China’s First: Meio Cardinav Medical’s Innovative Cardiac Electrophysiology Interventional Surgery Control System “TITIAN” Approved for Market Launch
November 14, 2025 On October 31st, the Cardiac Electrophysiology Interventional Surgery Control System, branded as “TITIAN” developed by Meio Cardinav Medical, received market approval from...
A Landmark Achievement: Robo Medical’s Endoscopic Robot Approved for the Chinese Market
In a groundbreaking development for medical technology, the National Medical Products Administration (NMPA) of China has granted market approval to Robo Medical for its Control...
Edge Medical Launches its CP1000 Robotic System in China, Revolutionising Thoracic Surgery
In a groundbreaking move to enhance precision and minimise patient trauma, Edge Medical, a Shenzhen-based innovative MedTech company, has unveiled its latest innovation in medical...
